Introduction

Coronary computed tomography angiography (CCTA) is a well-known, reliable method for detecting coronary stenosis in clinical workups of coronary artery disease (CAD) [1]. However, the anatomic assessment by CCTA using the criterion of diameter stenosis > 50% does not correlate well with the functional assessment of the fractional flow reserve (FFR), which is regarded as the gold standard for determining hemodynamically significant coronary stenosis [2,3,4]. To overcome the weaknesses of conventional CCTA, the transluminal attenuation gradient (TAG) [5,6,7], myocardial perfusion CT [8,9,10], and noninvasive fractional flow reserve-CT (FFR-CT) [11,12,13] were recently introduced, and their ability to assess physiological consequences during CT examinations has been tested. There has been progress in designing functional evaluations by myocardial perfusion CT and FFR-CT, but myocardial perfusion CT requires additional radiation exposure and contrast agents to scan at the stress and rest conditions [14]. In addition, FFR-CT involves high cost and long analysis times.

In contrast, TAG is calculated using a CCTA image acquired with a single contrast injection, and it is obtained without using special software. TAG is calculated by obtaining the linear regression coefficient between the luminal contrast attenuation and the distance along the vessel from the coronary ostium [5, 7, 15, 16]. The use of TAG can assist in the noninvasive assessment of hemodynamically significant coronary artery stenosis and flow [5,6,7]. However, several studies have reported that TAG has no incremental diagnostic value for the assessment of the hemodynamic consequences of coronary stenosis [17, 18]. One reason for this is that TAG depends on the scan timing after the injection of the contrast medium (CM) [19]; in that study, Funama et al. observed that the optimal scan time point for TAG is before rather than after the peak enhancement of coronary arteries. In other words, the scan timing of the peak contrast enhancement of coronary arteries is not suitable for obtaining the optimal TAG value.

However, TAG is generally calculated from a CCTA image obtained at the time point of the peak enhancement of coronary arteries. This might lower the diagnostic utility of the TAG. Another index that does not depend on the scan timing is thus required for the detection of ischemia. We hypothesized that the use of multi-phase TAGs around the peak contrast enhancement phase (including the optimal TAG) would improve the diagnostic ability to detect significant coronary artery stenosis.

13N-ammonia PET-MPI offers very high sensitivity, specificity, and overall diagnostic accuracy for the detection of myocardial ischemia [20,21,22,23,24,25]. The clinical superiority of 13N-ammonia PET-MPI was recognized in a joint statement of the American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging [26]. Herein, we propose a new dynamic TAG index (DTI) derived from dynamic 320-row CCTA (dynamic CCTA), and we conducted the present study to determine the diagnostic performance of the DTI for the detection of myocardial ischemia based on the 13N-ammonia PET-MPI results.

Materials and methods

Study population

We retrospectively analyzed the data of 48 consecutive patients who had undergone both dynamic CCTA and rest/adenosine stress 13N-ammonia positron emission tomography myocardial perfusion imaging (PET-MPI). All patients had been clinically referred for the assessment of known or suspected coronary artery disease (CAD). The CCTA was performed first for each patient, and 13N-ammonia PET-MPI was then performed to assess the presence of myocardial ischemia. In all patients, 13N-ammonia PET was performed within 3 months after the CCTA examination. Revascularization therapy was not performed during the interval.

The patient exclusion were as follows: (i) acute myocardial infarction (within 3 months); (ii) unstable angina (recent onset of angina within 1 month, or severe and worsening clinical symptoms); (iii) chronic atrial fibrillation; (iv) pregnancy, hyperthyroidism, or known allergic reaction to contrast media; (v) severe left ventricular dysfunction (left ventricular ejection fraction < 20%); (vi) known history of bronchial asthma; (vii) congestive heart failure (New York Heart Association class IV); and (viii) greater than first-degree atrioventricular block. A detailed medical history was recorded for each patient, with particular attention to evidence of hypertension, diabetes mellitus, and hyperlipidemia. All patients underwent a battery of laboratory tests, including tests for traditional atherosclerotic risk factors. The CAD risk factors considered in this study were hypertension, diabetes mellitus, hyperlipidemia, and smoking history. The patients' characteristics are summarized in Table 1. After the study's protocol was approved by the local ethics committee, informed consent for this retrospective analysis was obtained from all of the patients.

Table 1 Characteristics of 48 the patients with CAD

The CCTA scan conditions

All patients were examined on a 320-row CT scanner (Aquilion One Genesis Edition, Canon Medical Systems, Otawara, Japan). First, a test-bolus examination was performed using prospective electrocardiography (ECG)-gating axial scans at the ascending aorta at the slice level of the pulmonary trunk in mid-diastole for 15–25 cardiac cycles during a 20.0-s period starting at 7.0 s after the initiation of the bolus injection of the CM to determine the optimal scan timing for 320-row CCTA [27].

After the test-bolus examination, a dynamic CCTA scan was continuously performed in mid-diastole for five cardiac cycles with prospective ECG-gating axial scans after a 10-s CM injection of Iopamidol-370 (370 mgI/ml Iopamiron; Bayer HealthCare, Osaka, Japan) [42 ml (27–53 ml), 259 mgI/kg]. One scan of the dynamic CCTA was performed as a boost scan for standard CCTA at the peak phase of the ascending aorta, which was determined by the test-bolus examination (Fig. 1). The acquisition parameters are summarized in Table 2. The standard CCTA was analyzed using a workstation (Ziosoft, Tokyo, Japan) based on a combination of transverse sections and the automatically generated curved multiplanar reconstruction (MPR) images of the target vessels. A semi-automated vessel analysis tool was used for grading the severity of stenosis. Images were clinically interpreted by the consensus decision of two experienced radiologists, using the American Heart Association (AHA) 15-segment model [28]. Significant stenosis was defined as ≥ 50% stenosis in a major epicardial coronary artery segment with a dia. ≥ 2 mm [29].

Fig. 1
figure 1

Overview of the dynamic-CCTA methods

Table 2 The dynamic and boost CCTA scan parameters

Image analysis with some TAGs for dynamic CCTA

We performed the TAG analysis with a semi-automated method using a dedicated workstation (Vitrea, Canon Medical Systems, Otawara, Japan). The vessel centerline and contouring were automatically determined for each major coronary artery and were manually corrected if necessary. The RCA started at the ostial and ended the #3, LAD started at the ostial left coronary artery and ended the #8, and LCX started at the ostial left coronary artery and ended the #13. Cross-sectional images perpendicular to the vessel centerline were then reconstructed. The mean value of the luminal area was measured in Hounsfield units (HU) at 1-mm intervals, from the ostium to a distal level where the cross-sectional minimal area fell below 2.0 mm2. The data points in segments with motion or blooming artifacts from luminal calcium were manually excluded from the analysis. TAG is expressed as the change in HU per 10-mm length of coronary artery, defined as the linear regression coefficient between the intraluminal radiological attenuation and the distance from the ostium [5, 7, 15, 16, 30].

Absolute TAG values at five phases around the boost scan were calculated. We defined the DTI as the ratio of the maximum absolute TAG (TAGmax) to the standard deviation (SD) of five TAGs (Fig. 2). The TAG of the boost scan was defined as the ‘conventional TAG (C-TAG)’. The DTI and the C-TAG were determined for each of the RCA, LAD, and LCX.

Fig. 2
figure 2

Calculation of the dynamic TAG index (DTI). The DTI was defined as the ratio of the TAGmax to the standard deviation of five TAGs, which are at five phases around the peak enhancement. C-TAG the TAG at the boost scan, TEC time enhancement curve

Rest/adenosine stress 13N-ammonia PET-MPI

13N-ammonia PET images were obtained on a whole-body 64-row PET/CT scanner (Biograph-mCT®, Siemens Healthcare, Erlangen, Germany) with the 3D list mode protocol. A low-dose CT transmission scan was performed with respiratory gating or shallow-expiration breath-holding for attenuation correction. A 10-min 3D list mode scan was performed for both rest and stress within the interval of sufficient radioactive decay (40 min). For both the rest and stress scans, 740 MBq of 13N-ammonia was used from the right basilica vein via an automatic syringe pump, followed by 20 mL of saline at 40 mL/min. Adenosine stress (0.12 mg/min/kg) was administered 3 min prior to the stress scan and continued for 6 min.

Static and electrocardiogram-gated (16 bin) images were resampled from the list-mode data (120–600 s) and exported as a polar map using a 17-segment model. PET images were interpreted by two experienced cardiologists and a nuclear medicine physician. A summed differential score (SDS) > 2 per each coronary territory was defined as positive for myocardial ischemia. The SDS is the difference between the summed rest score (SRS) and summed stress score (SSS), representing the severity of ischemia. Based on each patient's 13N-ammonia PET-MPI results, we categorized the territories of the RCA, LAD, and LCX as non-ischemic or ischemic. Ischemic territory was defined as a territory that consisted of one or more segments of ischemia.

The CT radiation dose of the dynamic CCTA

We recorded the machine-generated volume CT dose index (mGy) and the dose-length product (DLP) for each dynamic CCTA scan. We also estimated the effective radiation dose to the chest using the following equation [31]:

$$\mathrm{Effective radiation dose}=\mathrm{DLP }\times 0.026 \left(\mathrm{mSv}\right).$$

Statistical analyses

All statistical analyses were performed using JMP vs. 13 software (SAS, Cary, NC, USA). Continuous variables are expressed as the mean ± SD, and categorical variables are expressed as frequencies and percentages. The DTI and C-TAG values for coronary territories with and without ischemia were compared using the Wilcoxon rank-sum test. We performed a receiver operating characteristic (ROC) curve analysis to determine the optimal cutoffs of the DTI and C-TAG for identifying ischemia as defined based on PET-MPI results [32]. Optimal cutoffs were determined by values with Youden J statistics. The incremental values of the DTI and the C-TAG to standard CCTA-derived diameter stenosis at ≥ 50% for the presence of ischemia were determined by comparing the respective area under the ROC curve (AUC) using the method of DeLong [33]. Probability values < 0.05 were accepted as significant.

Results

The results obtained with 13 N-ammonia PET-MPI and standard CCTA

The 13N-ammonia PET-MPI detected 27 ischemic territories (RCA, n = 8; LAD, n = 10; LCX, n = 9) in 22 of the 48 patients, and thus in the remaining 26 patients, no ischemic territory was observed. Of 22 patients with ischemic territory, two patients have prior myocardial infarction. We therefore used 27 ischemic and 117 normal territories as analytic targets.

We excluded five coronary arteries with severe stenosis or occlusion, seven arteries with motion artifacts, and six arteries with insufficient enhancement from the analysis because the DTI could not be measured. The DTI and the C-TAG were analyzed for a final total of 89 normal coronary arteries (RCA, n = 36; LAD, n = 22; LCX, n = 31) and 37 coronary arteries with ≥ 50% stenosis (RCA, n = 9; LAD, n = 19; LCX, n = 9). 88% of coronary artery could be evaluated by the DTI and C-TAG.

According to the 13N-ammonia PET-MPI results, the 37 territories with ≥ 50% stenosis consisted of 11 ischemic territories (30%) and 26 normal territories (70%). The 89 territories without stenosis consisted of 10 ischemic territories (11%) and 79 normal territories (89%).

The detection of ischemia by the DTI

The DTI was significantly higher for ischemia (8.8 ± 3.9) compared to non-ischemia (4.6 ± 2.0, p < 0.01). There was no significant difference in the C-TAG between the ischemia and non-ischemia groups (24.9 ± 9.0 vs. 20.9 ± 17.8 HU/cm, respectively; p = 0.19) (Fig. 3).

Fig. 3
figure 3

Comparison of the DTI (a) and the C-TAG (b) between ischemic and non-ischemic coronary territories. The DTI was significantly higher for ischemia than for non-ischemia. *p < 0.01, n.s. not significant

The ROC analysis revealed the DTI of 5.60 as the optimal cutoff to detect ischemia, with an AUC of 0.87, 85.7% sensitivity, and 76.2% specificity. For the C-TAG, 20.4 was the optimal cutoff point for detecting ischemia, with an AUC of 0.62, 76.2% sensitivity, and 57.1% specificity (Fig. 4). Representative cases are shown in Figs. 5 and 6.

Fig. 4
figure 4

ROC curves for the DTI and the C-TAG for ischemia. a DTI. b C-TAG. The AUC of the DTI was higher than that of the C-TAG

Fig. 5
figure 5

Straightened curved multiplanar reconstruction (MPR) images of the RCA and the TAGs at five different phases for a 46-year-old man with non-ischemia on PET-MPI. Moderate stenosis was observed in the patient's mid-RCA on CCTA. According to luminal attenuation (HU), the lumen of the coronary artery was delineated by a six-color scale. Warm colors represent high CT values, and cold colors represent low CT values. The change in the five TAGs was large, resulting in the DTI of 2.85

Fig. 6
figure 6

Straightened curved MPR images of the LCX and the TAGs at five different phases for an 80-year-old man with ischemia on PET-MPI. The patient had no significant coronary stenosis on CCTA. The color scale of the coronary artery is the same as in Fig. 5. The change in the five TAGs was small, resulting in the DTI of 6.88

The incremental diagnostic values of the DTI and the C-TAG for the presence of ischemia

The results of the ROC analyses regarding the incremental diagnostic values of the DTI and the C-TAG to CCTA-derived diameter stenosis alone for the presence of ischemia (as defined by PET-MPI) are illustrated in Fig. 7. The AUC was 0.89 (95%CI 0.78–0.99) for DTI + CCTA, 0.73 (95%CI 0.57–0.90) for C-TAG + CCTA, and 0.64 (95%CI 0.50–0.78) for CCTA alone. The addition of the DTI to CCTA significantly increased the AUC for the presence of ischemia (p = 0.0097). The addition of the C-TAG to CCTA did not significantly increase the AUC (p = 0.3622).

Fig. 7
figure 7

The diagnostic value of coronary CTA alone vs. coronary CTA with the DTI or the C-TAG for the presence of ischemia. The addition of the DTI to CCTA significantly increased the AUC for the presence of ischemia (p = 0.0097). The addition of the C-TAG to CCTA did not significantly increase the AUC (p = 0.36)

The radiation dose of dynamic CCTA and 13N -ammonia PET-MPI

The mean effective radiation dose was 8.6 ± 1.8 mSv for the dynamic CCTA. The mean effective radiation dose was 3.3 ± 0.1 mSv for 13N-ammonia PET-MPI.

Discussion

We assessed the diagnostic potential of the DTI and TAG for the presence of ischemia as defined by 13N-ammonia PET-MPI. Our analyses revealed that the DTI for ischemia was significantly higher than that for non-ischemia. However, there was no significant difference in the TAG between the ischemia and non-ischemia.

Several research groups reported that the use of TAG provided no additional diagnostic value for the assessment of the hemodynamic consequences of coronary stenosis [17, 18, 34, 35]. The major reasons for this are that TAG may be affected not only by ischemia but also by other factors such as the scanning method (volume or helical scanning) [36], the scan timing after the CM injection, and the injection methods (test bolus or bolus tracking). In our study, TAG was calculated using whole-heart volume scanning and the test-bolus method that was recommended for TAG analyses in a previous report [19]. However, our present findings are also in line with those of earlier studies [17, 18, 34, 35]. We observed that the use of TAG provided no additional diagnostic value for the detection of ischemia.

We thus propose the novel DTI index, which incorporates the following two important points — which were reported by Funama et al. [19]— in TAG analyses. First, TAG depends on the scan timing after the injection of the CM. The scan time to the peak contrast enhancement of coronary arteries is not appropriate for obtaining the optimal TAG value. We adjusted this timing by applying the maximum absolute TAG from the five phases around the peak enhancement of the coronary artery into the numerator of the DTI equation. Second, the variation in the TAGs without significant stenosis was larger than the variation in the TAGs with significant stenosis at the scan timing after the CM injection. We compensated for this by plugging the standard deviation (SD) of five TAGs into the denominator of the DTI equation. This SD reflects the contrast enhancement delay. We speculate that these two points make it possible that compared to a TAG, the DTI is more likely to reflect directly coronary flow. At the time of measuring TAG, the attenuation measurement along the center line of the coronary artery lumen is performed while avoiding the calcification of the vessels’ wall. Therefore, the DTI is less affected by coronary calcification.

Our present findings demonstrate that the DTI provided incremental diagnostic value over CCTA alone for the presence of ischemia as defined by PET-MPI. Several studies have shown that an anatomic assessment by CCTA using > 50% diameter stenosis does not correlate well with the functional assessment [2,3,4]. Similarly, based on the PET-MPI results in the present study, 27 cases with > 50% stenosis as shown by CCTA were diagnosed as normal. Of these, 19 (73%) cases were correctly diagnosed as normal by the DTI. Conversely, ten cases with < 50% stenosis by CCTA were diagnosed as ischemic. Of these, eight cases (80%) were correctly diagnosed as ischemic by the DTI. These results suggest that the use of the DTI combined with CCTA is more helpful in the functional assessment of coronary arteries. Hybrid analyses of the DTI and coronary stenosis derived from dynamic CCTA could have diagnostic ability that is comparable to that of stress/rest PET-MPI. Our method also reduces the burden on the patient because only the rest scan is taken.

Ideally, the anatomic and functional significance of coronary artery stenosis should be determined by a single noninvasive imaging examination. A hybrid analysis of DTI and CCTA results derived from dynamic CCTA can be performed for functional and anatomic assessments with a single contrast injection and a CT examination without additional cost or special software. The mean time for post-processing analysis of the DTI was 20 min. It is possible to analyze and obtain results immediately after CCTA scan. Moreover, this imaging technique can also visualize the coronary flow for dynamic color-coding [37].

There are some advantages of CT approach respect to 13N-ammonia PET-MPI in terms of availability. First, the cost of CCTA is about one-third that of PET. Second, there can be more than ten CCTA examinations per day. On the other hand, there is a limit to the amount of ammonia produced by the cyclotron, and only three examinations per day are possible. Third, the CT examination time is approximately 30 min, which is shorter than the PET examination time of approximately 70 min. The features of DTI technique were summarized as follows: (1) direct coronary flow quantification, (2) data can be obtained from routine clinical workup, and (3) it can contribute as additional functional test over standard CCTA interpretation.

This study has several limitations. First, this study is a retrospective single-center study, the patient cohort is relatively small. Our findings thus require confirmation in larger multicenter studies. Second, coronary arteries with a cross-sectional area > 2.0 mm2 appear to be necessary for a DTI analysis, because the vessel centerline and contouring cannot be accurately extracted in smaller arteries. The application of the DTI in smaller vessels may be a limitation. Third, the calculation of DTI requires 320-slice CT scanner that enables a single volume scan for the whole heart, and 64- or 128-slice CT scanners is not suitable. Moreover, the utility of the DTI must also be validated using more current acquisition and reconstruction protocols, such as the model-based iterative reconstruction or deep learning-based reconstruction which can reduce image noise [38, 39]. These reconstruction methods may be useful for obese patients with high image noise. Fourth, sufficient contrast enhancement and less motion artifacts of coronary arteries at continuous five data must be achieved to determine the DTI. In this study, the rate of exclusion from the analysis of coronary segments due to these effects was 9% of the whole dynamic images.

PET analysis was limited to visual evaluation using SDS and no quantitative evaluation was performed. Myocardial blood flow and myocardial flow reserve are affected by age, lifestyle-related diseases, renal function, and microvascular disease. In this study, ischemic diagnosis by SDS was used as a standard to make one-to-one correspondence between coronary arteries and their perfusion regions.

Conclusion

We proposed the DTI as a novel coronary flow index for use with dynamic CCTA. The DTI value for ischemia was significantly higher than that for non-ischemia, and its use added value to coronary CTA for the detection of myocardial ischemia. Hybrid analyses of the DTI and CCTA results derived from dynamic CCTA can be performed for functional and anatomic imaging with a single contrast injection and a CT examination.